Read by QxMD icon Read


Salina Zhang, Pelin Batur, Charles Martin, Paul J Rochon
As the reversible contraceptive arm implants grow more popular, there is an increasing need to recognize the complications resulting from implant migration and removal. This review summarizes the findings of imaging and removal methods. When an implant is lost, the axillary region should be investigated first. If the implant still cannot be found, visualization though different methods have been employed for non-radiopaque implants. Real-time fluoroscopic-guided localization and removal can be accomplished for radiopaque Nexplanon...
March 2018: Seminars in Interventional Radiology
Julien Chevreau, David Krief, Osama Abou Arab, Mickaël Zitoun, Arthur Foulon, Fabrice Sergent, Jean Gondry
OBJECTIVES: Nexplanon® 's new applicator system was designed to limit deep implant placements, known to lead to difficult removals. However, removal difficulties still exist and induce specific and potentially severe complications. Our objective was to identify risk factors associated with difficult removals. STUDY DESIGN: A retrospective single-center study was performed from January 2015 to December 2016. Participants were divided into two groups depending on whether implant was removed during a standard ("standard removal" group) or difficult consultation ("difficult removal" group) after an initial failed removal attempt...
March 13, 2018: European Journal of Obstetrics, Gynecology, and Reproductive Biology
Gabriel T Gao, William Binder
Nexplanon is a long-acting 4cm radio-opaque rod shaped contraceptive device implanted in the subdermal layer of the inner, upper arm. Complications from implantation are uncommon and mostly local and minor, including infection at the implantation site with resulting cellulitis or abscess, hematoma, abnormal scar formation, or local damage to nerves and blood vessels. Intravascular insertion is estimated to be at 1.3 per million Nexplanon implants, and migration and embolization is a rare complication of this device...
March 3, 2018: American Journal of Emergency Medicine
Margaret Thew
Long-acting reversible contraception, which include etonogestrel subdermal hormonal implants, has high efficiency rates in preventing teen pregnancy. Although these numbers are increasing, teens have the lowest long-acting reversible contraception usage rate of any group, which the American Congress of Obstetricians and Gynecologists addressed with recommendations for Nexplanon placement for teens. The American Congress of Obstetricians and Gynecologists has recommended support for increased use and training of practitioners and pediatricians to gain momentum...
2017: Global Pediatric Health
Bonnie C Crouthamel, Melissa A Schiff, Anne-Marie E Amies Oelschlager, Sarah W Prager, Katherine E Debiec
STUDY OBJECTIVE: The fracture of hormonal implants, including Implanon, Nexplanon, and histrelin acetate is rare. Our aim was to describe patient demographics, mechanisms, and consequences of fractured implants by surveying physicians' experience via listservs and social media. DESIGN: We developed a REDCap survey for physicians regarding their experience with implant fracture, including patient characteristics, mechanism of fracture, changes in menstrual bleeding patterns, time from insertion to fracture, and time from fracture to seeking care...
October 10, 2017: Journal of Pediatric and Adolescent Gynecology
Rachel Barlow-Evans, Kulsum Jaffer, Moji Balogun
This is a case report of a 17-year-old woman who experienced distant intravascular migration of a radio-opaque Nexplanon contraceptive implant. She presented with an impalpable implant and this was located using CT in the left lower lobe pulmonary artery. Significant migration of a contraceptive implant is an uncommon risk. Using radio-opaque contraceptive implants such as Nexplanon increases the ability to locate them if migration occurs.
May 12, 2017: BMJ Case Reports
Jennifer Paul, Christy M Boraas, Mildred Duvet, Judy C Chang
BACKGROUND: Since the internet has become an important source of contraceptive information with as the second most visited site, we analysed contraceptive implant YouTube videos for content and clinical accuracy. METHODS: Using the terms 'contraceptive implant', 'Nexplanon' and 'Implanon', the top 20 results on YouTube by relevance and view count were identified. After excluding duplicates, single-rod implant videos in English were included. Videos were classified as providing a professional or patient perspective...
January 20, 2017: Journal of Family Planning and Reproductive Health Care
Manaswi Sangraula, Samantha Garbers, Janet Garth, Emily Birchfield Shakibnia, Sarah Timmons, Melanie A Gold
STUDY OBJECTIVE, DESIGN, AND SETTING: Adolescents face barriers to accessing youth-friendly family planning services, specifically long-acting reversible contraception (LARC). School-based health centers (SBHCs) can provide youth-friendly care. A quality improvement project was undertaken to assess quality of care before, during, and after LARC services at 3 SBHCs, and to identify specific strategies for improving these LARC services. PARTICIPANTS, INTERVENTIONS, AND MAIN OUTCOME MEASURES: We interviewed 18 female adolescents who received LARC services...
June 2017: Journal of Pediatric and Adolescent Gynecology
Daniela Diego, Erryn Tappy, Jose Carugno
A 19-year-old patient presented to the clinic, and we inserted a single rod subdermal etonogestrel implant (Nexplanon ®), which subsequently migrated to the ipsilateral axilla. Distant Nexplanon® migration is a rare serious complication that should be considered when a device is nonpalpable. Management options are discussed.
February 2017: Contraception
(no author information available yet)
▼Canagliflozin and risk of lower limb amputation ● Antidepressants and young people ● Biological interventions for fatigue in RA ● Body shape in early and midlife linked to mortality ● COPD: LABA plus LAMA versus LABA plus ICS ● Safety warning for Nexplanon (etonogesterel) contraceptive implants ● Incorporating long-term prognosis into the care of older adults ● Impact of moderate-to-vigorous physical activity on cancer risk.
August 2016: Drug and Therapeutics Bulletin
C Simon, M S Agier, J Béné, C Muller, L Vrignaud, H Marret, A P Jonville-Bera
OBJECTIVES: The aim of the study was to assess the incidence of adverse effects (AE) reported with etonogestrel contraceptive implant in France (Implanon(®) and Nexplanon(®)). MATERIALS AND METHODS: All cases of AE or unintended pregnancies reported to health authorities or to the firm were analyzed. RESULTS: During 10 years, 5433 AE and 789 unintended pregnancies were reported. Only 388 (7 %) were serious. There were 1137 reports of difficulties to remove, failure to locate or migration, 430 of insertion difficulties and 203 of deformation or expulsion of the implant...
November 2016: Journal de Gynécologie, Obstétrique et Biologie de la Reproduction
Alison M Stuebe, Amy G Bryant, Robyn Lewis, Anitha Muddana
BACKGROUND: Studies have not found that hormonal contraceptive implants adversely affect breastfeeding, but theoretical concerns exist. METHODS: We reported a case of reduced weight gain in an exclusively breastfed infant in association with placement of (ENG)-releasing contraceptive implant (Nexplanon) to the FDA Adverse Events Reporting System (FAERS). We further queried reports to FAERS and reviewed published studies of the ENG implant during breastfeeding. RESULTS: A breastfeeding mother received an ENG implant at 4 weeks postpartum...
May 2016: Breastfeeding Medicine: the Official Journal of the Academy of Breastfeeding Medicine
Kim C Dobromilsky, Penny L Allen, Stephen H Raymond, Bhavna Maindiratta
BACKGROUND: Etonogestrel (ENG) implants (Implanon(®)/Nexplanon(®)/Implanon NXT(®)) are employed as contraception in early postpartum patients. Follow-up is often not conducted by the hospital prescriber. Little is known about duration of lochia, in a modern setting, and even less is known about the effect of ENG implants on lochia. AIMS: To determine if early postpartum (pre-discharge) insertion of Implanon for contraception was associated with a significant difference in duration of lochia...
July 2016: Journal of Family Planning and Reproductive Health Care
A Lafuma, A Agostini, T Linet, J Robert, L Levy-Bachelot, C Godard
No abstract text is available yet for this article.
November 2015: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Lucy Michie, Sharon T Cameron, Anna Glasier, Anne Johnstone
BACKGROUND: To provide standardised information about the contraceptive implant (Nexplanon(®)), a digital video disc (DVD) was developed for use within a sexual and reproductive health (SRH) service in Edinburgh. The aim was to determine if the accuracy of information recalled after watching a DVD was comparable to that following a face-to-face consultation, and if patients found the use of a DVD acceptable. METHODS: Fifty women attending an SRH service abortion clinic considering using Nexplanon for the first time agreed to be randomised to receive information about the implant either by (a) a DVD (n=35) developed using information taken from Faculty of Sexual & Reproductive Healthcare guidance or (b) a face-to-face consultation (n=15)...
July 2016: Journal of Family Planning and Reproductive Health Care
Costantino Di Carlo, Maurizio Guida, Nicoletta De Rosa, Anna Sansone, Virginia Gargano, Angelo Cagnacci, Carmine Nappi
PURPOSE: The purpose of this study is to evaluate the menstrual profile in users of the etonogestrel (ENG)-releasing implant (Nexplanon®) and the possible correlation with anthropometric variables. METHODS: Ninety-two healthy women, desiring long-term contraception with the ENG implant were enrolled in a prospective observational study. Anthropometric variables were measured at baseline and after 3, 6, 9, and 12 months. Patients recorded daily the occurrence of any bleeding or spotting...
June 2015: Gynecological Endocrinology
Célia Pedroso, Isabel Martins, Fátima Palma, Ana Isabel Machado
Nexplanon (Schering-Plough Limited/Merck Sharp & Dohme Limited (MSD)) is a long active reversible contraceptive method that provides effective contraception for 3 years. It consists of a single, flexible, rod-shaped implant, containing 68 mg etonogestrel. It is 4 cm long, consists of an ethylene vinyl acetate copolymer, a non-absorbable material, and also contains 15 mg of barium sulfate, which makes it visible by X-ray. We describe a case of a 39-year-old woman who experienced a local reaction to the barium sulfate in Nexplanon...
May 7, 2015: BMJ Case Reports
Deepak Khatri
No abstract text is available yet for this article.
January 2015: Journal of Family Planning and Reproductive Health Care
Anne Connolly, Guilhem Pietri, Jingbo Yu, Samantha Humphreys
BACKGROUND: Since the late 1990s, the British government has launched major strategies to address high teenage pregnancy and abortion rates in England. These have focused in part on improving access to contraception through national campaigns. This study assessed teenage pregnancy and abortion rate trends since 1998 and possible associations with usage of long-acting reversible contraceptives (LARCs). METHODS: Teenage conception rates and age-specific abortion rates were obtained from the Office for National Statistics and the Department of Health...
2014: International Journal of Women's Health
Maurizio Serati, Giorgio Bogani, Sanjeev Kumar, Antonella Cromi, Fabio Ghezzi
Nexplanon® is an etonogestrel implant with a long-acting contraceptive effect. Although several studies underlined its safety profile, its implant can rarely lead to moderate or severe adverse event. Here, we presented a case of delayed-type hypersensitivity reaction against Nexplanon® that resolved after its removal.
January 2015: Contraception
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"